Ā | Evidence of CE (nā=ā109) | No evidence of CE (nā=ā20) | p-value |
---|---|---|---|
Sex, n (%) | Ā | Ā | 0.47 |
āMale | 54 (49.5%) | 8 (40.0%) | Ā |
āFemale | 55 (50.5%) | 12 (60.0%) | Ā |
Mean age, years | 48.1āĀ±ā22.9 | 50.1āĀ±ā20.7 | 0.34 |
Mean ISS | 26.2āĀ±ā12.5 | 28.4āĀ±ā9.8 | 0.13 |
Time from order to angiography, min | 64.6āĀ±ā47.2 | 62.9āĀ±ā30.7 | 0.67 |
Repeat AE, n (%) | 3 (2.8%) | 2 (10.0%) | 0.17 |
Fracture classification, n (%) | Ā | Ā | 0.68 |
āStable ring | 30 (27.5%) | 6 (30.0%) | Ā |
āPartially stable ring | 32 (29.3%) | 4 (20.0%) | Ā |
āUnstable ring | 47 (43.2%) | 10 (50.0%) | Ā |
Mean blood transfusion (mL) | 2348.1āĀ±ā2727.0 | 2606.0āĀ±ā2097.2 | 0.25 |
Embolization material | Ā | Ā | 0.23 |
āGelfoam | 101(92.7%) | 17(85.0%) | Ā |
āMetal coils | 8(7.3%) | 3(15.0%) | Ā |
Osteosynthesis for pelvic fracture, n (%) | 62 (56.9%) | 13 (65.0%) | 0.32 |
Embolization of BIIA, n (%) | 82 (75.2%) | 15 (75.0%) | 0.59 |
Mortality, n (%) | 12 (11.0%) | 6 (30.0%) | 0.03 |